Monday, November 7, 2016

Stanford uses CRISPR to correct sickle cell, human trials planned

CHICAGO, Nov 7 (Reuters) - Scientists at Stanford University

School of Medicine have used the CRISPR gene editing tool to

repair the gene that causes sickle cell disease in stem cells

from diseased patients, paving the way for a potential cure for

the disease, which affects up to 5 million people globally.

Read more

No comments:

Post a Comment